Kenneth Allen Myszkowski, Chief Financial Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 40,000 shares at $35.19 ($1.4M) on 2024-03-06, disclosed to the SEC on 2024-03-08.
Open-market sale of $1.4M ARWR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ARWR | SELL | 2023-06-29 | $543K | — | Filing → |
| ARWR | SELL | 2022-12-30 | $1.2M | — | Filing → |
| ARWR | SELL | 2022-01-06 | $2.9M | — | Filing → |